Article

3 Pivotal Biopharma Growth Drivers Reshaping 2025 and Beyond

Cencora and STAT Open Doors Event

Learn more about what is driving growth in 2025 and beyond

The biopharma industry is evolving rapidly, shaped by innovation, economic pressures, and global dynamics. On June 17, 2025, Cencora executives and industry leaders explored key growth drivers such as channel strategy, global market expansion and localization, and AI-driven innovation and Automation during an engaging STAT Open Doors session.

Speakers:

  • Eric Monzon, SVP, Enterprise Solutions and Sales at Cencora (Moderator)
  • Sandra Anderson, SVP, Commercialization at Cencora
  • David Senior, SVP, Market Economics, Intelligence, & Influence at Cencora
  • Kelly Price, Managing Director US, Esteve
  • Harpreet Sandu, Executive Director, Market Access Cross Portfolio, Gilead

Fill out the form to download the recording

Pardot Form

We’re here to help

Connect with our team today to learn more about how Cencora is helping to shape the future of healthcare.

Related resources

Article

Optimizing the channel strategy to expand patient access to cell and gene therapies
CGT cells

Webinar

Best Practices for Building a Channel Strategy: Lessons Learned and Forward-Thinking Initiatives to Maximize Market Reach
Abstract 1

Webinar

Optimizing Channel Strategy to Overcome CGT-Specific Barriers

Cencora.com is providing automated translations to assist in reading the website in languages other than English. For these translations, reasonable efforts have been made to provide an accurate translation, however, no automated translation is perfect nor is it intended to replace human translators. These translations are provided as a service to users of Cencora.com and are provided "as is." No warranty of any kind, either expressed or implied, is made as to the accuracy, reliability, or correctness of any of these translations made from English into any other language. Some content (such as images, videos, Flash, etc.) may not be accurately translated due to the limitations of the translation software.

Any discrepancies or differences created in translating this content from English into another language are not binding and have no legal effect for compliance, enforcement, or any other purpose. If any errors are identified, please contact us. If any questions arise related to the accuracy of the information contained in these translations, please refer to the English version of the page.